1. 568. THE PROGNOSTIC EFFECT OF PATHOLOGICAL LYMPH NODE REGRESSION AFTER NEOADJUVANT CHEMOTHERAPY FOR OESOPHAGEAL ADENOCARCINOMA – A MULTICENTRE STUDY. (24th September 2022) Authors: Moore, Jonathan; Green, Michael; Van Hemelrijck, Mieke; Deere, Harriet; Evans, Richard PT; Elshafie, Mona; Lavery, Anita; McGuigan, Andrew; Douglas, Rosalie; Mcmanus, Damian; Horne, Joanne; Walker, Robert; Mir, Hira; Terlizzo, Monica; Kamarajah, Sivesh K; Santaolalla, Aida; Maisey, Nick; Lumsden,... Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Consensus recommendations for the standardized histopathological evaluation and reporting after radical oesophago-gastrectomy (HERO consensus). Issue 8 (8th May 2021) Authors: Pucher, Philip H; Allum, William H; Bateman, Adrian C; Green, Michael; Maynard, Nick; Novelli, Marco; Petty, Russell; Underwood, Timothy J; Gossage, James Journal: Diseases of the esophagus Issue: Volume 34:Issue 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study. Issue 10 (October 2021) Authors: Muti, Hannah Sophie; Heij, Lara Rosaline; Keller, Gisela; Kohlruss, Meike; Langer, Rupert; Dislich, Bastian; Cheong, Jae-Ho; Kim, Young-Woo; Kim, Hyunki; Kook, Myeong-Cherl; Cunningham, David; Allum, William H; Langley, Ruth E; Nankivell, Matthew G; Quirke, Philip; Hayden, Jeremy D; West, Nichola... Journal: Lancet Issue: Volume 3:Issue 10(2021) Page Start: e654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Guidelines for the management of oesophageal and gastric cancer. Issue 11 (24th June 2011) Authors: Allum, William H; Blazeby, Jane M; Griffin, S Michael; Cunningham, David; Jankowski, Janusz A; Wong, Rachel Journal: Gut Issue: Volume 60:Issue 11(2011) Page Start: 1449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial. Issue 8 (27th June 2020) Authors: Davarzani, Naser; Hewitt, Lindsay C; Hale, Matthew D; Melotte, Veerle; Nankivell, Matthew; Hutchins, Gordon G A; Cunningham, David; Allum, William H; Langley, Ruth E; Jolani, Shahab; Grabsch, Heike I Journal: Diseases of the esophagus Issue: Volume 33:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. Issue 3 (March 2017) Authors: Cunningham, David; Stenning, Sally P; Smyth, Elizabeth C; Okines, Alicia F; Allum, William H; Rowley, Sam; Stevenson, Laura; Grabsch, Heike I; Alderson, Derek; Crosby, Thomas; Griffin, S Michael; Mansoor, Wasat; Coxon, Fareeda Y; Falk, Stephen J; Darby, Suzanne; Sumpter, Kate A; Blazeby, Jane M; ... Journal: Lancet oncology Issue: Volume 18:Issue 3(2017:Mar.) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma – Authors' reply. Issue 5 (May 2017) Authors: Smyth, Elizabeth C; Allum, William H; Rowley, Samuel; Langley, Ruth E; Cunningham, David Journal: Lancet oncology Issue: Volume 18:Issue 5(2017:May) Page Start: e244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Issue 2 (4th November 2011) Authors: Andreyev, H Jervoise N; Davidson, Susan E; Gillespie, Catherine; Allum, William H; Swarbrick, Edwin Journal: Gut Issue: Volume 61:Issue 2(2012) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial. Issue 7 (25th March 2018) Authors: Davarzani, Nasser; Hutchins, Gordon G A; West, Nicholas P; Hewitt, Lindsay C; Nankivell, Matthew; Cunningham, David; Allum, William H; Smyth, Elizabeth; Valeri, Nicola; Langley, Ruth E; Grabsch, Heike I Journal: Histopathology Issue: Volume 72:Issue 7(2018) Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Role of frailty assessment in selection for cancer surgery. Issue 5 (18th October 2022) Authors: Allum, William H Journal: BJS open Issue: Volume 6:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗